The most popular searches in Psychiatric Times during 2016, in alphabetical order. Scroll through the slides for links to stories that relate to search terms. View in PDF format.
Persons taking any kind of antipsychotic medication need to be monitored for movement disorders. The AIMS (Abnormal Involuntary Movement Scale) aids in the early detection of tardive dyskinesia as well as providing a method for on-going surveillance. For more information, download our clinical scales app.
Auditory hallucinations in schizophrenia, as well as both depressive and psychotic symptoms, can complicate diagnosis and treatment. Albert H. C. Wong, MD, PhD explores these matters in Psychosis-Depression Interface: Clinical Implications. Also discussed are the obvious differences between feelings of depression and associated neurovegetative symptoms, as well as the hallucinations and delusions of psychosis, with accumulating evidence of shared causes.
Narsimha R. Pinninti, MD and Rama Rao Gogineni, MD wrote in Brief Cognitive Behavioral Therapy Interventions for Psychosis that psychotherapeutic interventions can be critical in recovery from psychosis. This is especially true in institutional, community, and crisis settings that provide evaluations and medication management.
In this brief podcast, John Torous, MD interviews Rafael A Calvo, PhD about an emerging field at the intersection of mental health and technology: Positive Computing and Designing for Mental Health. Dr. Torous is Clinical Fellow in Psychiatry at Harvard Medical School and Senior Resident at the Harvard Longwood Psychiatry Residency Training Program in Boston. He is Digital Psychiatry Editor at Psychiatric Times.
Substantial progress has been made in the development of etiologic models of intimate partner violence (IPV) and interventions for individuals who assault their intimate partners. However, one survey reported that almost 7 million women and 5.5 million men experienced physical violence, stalking, or rape by an intimate partner each year. In Interventions for Perpetrators of Intimate Partner Violence, Christopher I. Eckhardt, PhD and colleagues reported on IPV, which continues to be a challenge for health providers since publication of this article in 2014.
Douglas H. Ingram, MD covered the topic in his 2012 article Who Was Karen Horney? He observed, “She hammered away at Freud’s endorsement of a conservative cultural belief system that gave male superiority an endorsement from biology. She began her own school, which energized what would soon play a major role in the Neo-Freudian orientation to psychoanalytic or, more inclusively, ‘psychodynamic’ thinking.”
Suicide and self-harm are often linked to impulsivity, but what other, less extreme, symptoms and scenarios can arise? In A Case of Gambling Disorder, Iman Parhami, MD, MPH and Timothy Fong, MD write about a patient brought to the emergency department by her daughter for bizarre behavior and symptoms of mania after gambling from the casino for 48 continuous hours.
Conceptualizations and diagnostic definitions of narcissistic personality disorder (NPD) have primarily focused on the more strikingly provocative behaviors and attitudes that tend to capture the attention of clinicians rather than on the patient’s underlying, internal struggles. This has contributed to making the diagnosis more judgmental rather than informative. In New Insights Into Narcissistic Personality Disorder, Elsa Ronningstam, PhD reports on the major advances in recent clinical and empirical studies of NPD, including the recognition of co-occurring vulnerability (eg, insecurity, inferiority, fragility) that accompanies emotion dysregulation.
Thousands of cases in psychiatric practice involve negative symptoms in schizophrenia. Negative symptoms, often confused with anhedonia, are common in individuals with schizophrenia. Patients and relatives are often unaware of the extent of these symptoms and seldom communicate them to the clinician. In 2016, we presented 5 Domains of Negative Symptoms of Schizophrenia by Dawn I. Velligan, PhD and Larry D. Alphs, PhD.
There is a relative paucity of information on treatment of late-life treatment-resistant depression (TRD). We conducted a survey of the readership of Psychiatric Times to assess the general attitudes toward the prevalence of—and the existing treatment approaches toward—TRD in adults 60 years and older. In Treatment Options in Late-Life Treatment-Resistant Depression, Helen Lavretsky, MD and colleagues present the results of that survey.